Customer Care Tel: 0161 483 5884
Email: ukcustomer@alere.com
Website: www.alere.co.uk
Our goal is to ensure the appropriate use of diagnostics to deliver improved health outcomes, better patient experiences and more cost effective care pathways.
In the field of Virology/Serolgy we offer high quality molecular, ELISA, and rapid tests covering an extensive range of diseases, with complementary automation options. We also offer the most comprehensive range of molecular and serological QC available.
![Image of [i]S. pneumo[/i] and Legionella in CAP Patient Pathway](/images/content/thumbs/0_ca_7016b7c7f3924c9c8fe8ef5dd5d3a6ec.jpg)
We asked delegates could the implementation of Pathway B bring benefits to your hospital?
If you were the patient, what would you want? A summary of your views on HIV and CD4 count patient pathways.
![Image of Alere sponsors new HIV campaign: Make (+) More Positive[tm]](/images/content/thumbs/0_ca_31a1d996be59296f5564fb8211ceb4f2.jpg)
Connecting people around the world who have been affected by HIV/AIDS.
![Image of [i]H. pylori[/i] Antigen Testing: Pulling together](/images/content/thumbs/0_ca_f420088acaa26cafecf5981ec247fdf5.jpg)
Oxoid IDEIA Amplified Hp StAR and Dynex DS2 from Alere Ltd; providing the complete automation package for Helicobacter pylori testing.
We asked delegates could the implementation of Pathway B bring benefits to your hospital?
We asked delegates could the implementation of Pathway B bring benefits to your hospital?
At the 2011 Biomedical Science Congress Alere conducted market research and surveyed over 700 laboratory based scientists.
Many thanks to those that took the time to complete one of our Changes in Pathology Review forms at the 2011 IBMS Congress.